FI944134A - Virustenvastaisia nukleosidianalogeja - Google Patents
Virustenvastaisia nukleosidianalogeja Download PDFInfo
- Publication number
- FI944134A FI944134A FI944134A FI944134A FI944134A FI 944134 A FI944134 A FI 944134A FI 944134 A FI944134 A FI 944134A FI 944134 A FI944134 A FI 944134A FI 944134 A FI944134 A FI 944134A
- Authority
- FI
- Finland
- Prior art keywords
- antiviral
- nucleocide
- analogues
- substituted
- benzimidazole base
- Prior art date
Links
- 230000000840 anti-viral effect Effects 0.000 title abstract 2
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 241000701022 Cytomegalovirus Species 0.000 abstract 1
- 125000002837 carbocyclic group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 208000002672 hepatitis B Diseases 0.000 abstract 1
- 229940127073 nucleoside analogue Drugs 0.000 abstract 1
- 241001529453 unidentified herpesvirus Species 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
- C07D235/08—Radicals containing only hydrogen and carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/26—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/28—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D235/30—Nitrogen atoms not forming part of a nitro radical
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB929205071A GB9205071D0 (en) | 1992-03-09 | 1992-03-09 | Therapeutic nucleosides |
| PCT/GB1993/000479 WO1993018009A1 (en) | 1992-03-09 | 1993-03-08 | Antiviral nucleoside analogues |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI944134A0 FI944134A0 (fi) | 1994-09-08 |
| FI944134A true FI944134A (fi) | 1994-11-07 |
Family
ID=10711750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI944134A FI944134A (fi) | 1992-03-09 | 1994-09-08 | Virustenvastaisia nukleosidianalogeja |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US5534535A (fi) |
| EP (1) | EP0630368B1 (fi) |
| JP (1) | JP3450854B2 (fi) |
| KR (2) | KR950700887A (fi) |
| AT (1) | ATE170846T1 (fi) |
| AU (1) | AU672597B2 (fi) |
| CA (1) | CA2131693A1 (fi) |
| CZ (1) | CZ209494A3 (fi) |
| DE (1) | DE69320945T2 (fi) |
| DK (1) | DK0630368T3 (fi) |
| ES (1) | ES2123048T3 (fi) |
| FI (1) | FI944134A (fi) |
| GB (1) | GB9205071D0 (fi) |
| HU (1) | HUT68445A (fi) |
| IL (1) | IL104976A (fi) |
| NZ (1) | NZ249554A (fi) |
| RU (1) | RU2141952C1 (fi) |
| TW (1) | TW366339B (fi) |
| WO (1) | WO1993018009A1 (fi) |
| ZA (1) | ZA931647B (fi) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9205071D0 (en) * | 1992-03-09 | 1992-04-22 | Wellcome Found | Therapeutic nucleosides |
| GB9413724D0 (en) * | 1994-07-07 | 1994-08-24 | Wellcome Found | Therapeutic nucleosides |
| NZ294095A (en) * | 1994-09-09 | 1998-08-26 | Wellcome Found | Antiviral purine nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring |
| US5811073A (en) * | 1995-06-19 | 1998-09-22 | President And Fellows Of Harvard College | Method for radioisotopic detection and localization of inflammation in a host |
| US5912356A (en) * | 1995-09-11 | 1999-06-15 | Glaxo Wellcome Inc. | Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring |
| GB9600143D0 (en) | 1996-01-05 | 1996-03-06 | Wellcome Found | Therapeutic compounds |
| GB9600142D0 (en) * | 1996-01-05 | 1996-03-06 | Wellcome Found | Chemical compounds |
| JP2001512453A (ja) | 1997-02-13 | 2001-08-21 | グラックス グループ リミテッド | ベンゾイミダゾール誘導体 |
| SK284810B6 (sk) * | 1997-05-13 | 2005-12-01 | Lonza Ag | Spôsob výroby (1S,4R)- alebo (1R,4S)-4-(2-amino-6-chlór-9-H- purín-9-yl)-2-cyklopentén-1-metanolu |
| NZ501415A (en) | 1997-06-10 | 2001-10-26 | Glaxo Group Ltd | Benzimidazole derivatives (optionally with saccharide substituents) useful for the treatment or prophylaxis of viral infections (particularly herpes, cytomegalovirus and Hepatitis B) or for the treatment or prophylaxis of restenosis |
| PL338454A1 (en) | 1997-07-30 | 2000-11-06 | Univ Michigan | Lixofuranosilbenzimidazoles as antiviral agents |
| US6514979B1 (en) | 1999-03-03 | 2003-02-04 | University Of Maryland Biotechnology Institute | Synergistic combinations of guanosine analog reverse transcriptase inhibitors and inosine monophosphate dehydrogenese inhibitors and uses therefor |
| GB0008939D0 (en) | 2000-04-11 | 2000-05-31 | Glaxo Group Ltd | Process for preparing substituted benzimidazole compounds |
| JP2003532643A (ja) | 2000-04-13 | 2003-11-05 | フアーマセツト・リミテツド | 肝炎ウイルス感染症を治療するための３’−または２’−ヒドロキシメチル置換ヌクレオシド誘導体 |
| TW200831081A (en) | 2006-12-25 | 2008-08-01 | Kyorin Seiyaku Kk | Glucokinase activator |
| RU2553476C2 (ru) | 2007-08-02 | 2015-06-20 | Миллениум Фармасьютикалз, Инк. | Способ синтеза ингибиторов е1-активирующего фермента |
| PT2275414E (pt) | 2008-04-28 | 2015-09-09 | Teijin Pharma Ltd | Derivado de amida do ácido ciclopentacrílico |
| US11499722B2 (en) * | 2020-04-30 | 2022-11-15 | Bsh Home Appliances Corporation | Household cooking appliance having an oven door with an interior camera |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4996308A (en) * | 1988-03-25 | 1991-02-26 | Merrell Dow Pharmaceuticals Inc. | Derivatives with unsaturated substitutions for the 5'-hydroxymethyl group |
| ZA894534B (en) * | 1988-06-20 | 1990-03-28 | Merrell Dow Pharma | Novel neplanocin derivatives |
| GB8826205D0 (en) * | 1988-11-09 | 1988-12-14 | Wellcome Found | Heterocyclic compounds |
| GB8926417D0 (en) * | 1989-11-22 | 1990-01-10 | Wellcome Found | Heterocyclic compounds |
| MY104575A (en) * | 1989-12-22 | 1994-04-30 | The Wellcome Foundation Ltd | Therapeutic nucleosides. |
| US5248672A (en) * | 1990-11-01 | 1993-09-28 | The Regents Of The University Of Michigan | Polysubstituted benzimidazole nucleosides as antiviral agents |
| GB9205071D0 (en) * | 1992-03-09 | 1992-04-22 | Wellcome Found | Therapeutic nucleosides |
-
1992
- 1992-03-09 GB GB929205071A patent/GB9205071D0/en active Pending
-
1993
- 1993-03-08 DK DK93905536T patent/DK0630368T3/da active
- 1993-03-08 EP EP93905536A patent/EP0630368B1/en not_active Expired - Lifetime
- 1993-03-08 ES ES93905536T patent/ES2123048T3/es not_active Expired - Lifetime
- 1993-03-08 IL IL10497693A patent/IL104976A/en not_active IP Right Cessation
- 1993-03-08 CA CA002131693A patent/CA2131693A1/en not_active Abandoned
- 1993-03-08 CZ CZ942094A patent/CZ209494A3/cs unknown
- 1993-03-08 NZ NZ249554A patent/NZ249554A/en unknown
- 1993-03-08 RU RU94043771A patent/RU2141952C1/ru active
- 1993-03-08 JP JP51547193A patent/JP3450854B2/ja not_active Expired - Fee Related
- 1993-03-08 DE DE69320945T patent/DE69320945T2/de not_active Expired - Fee Related
- 1993-03-08 AU AU36432/93A patent/AU672597B2/en not_active Ceased
- 1993-03-08 ZA ZA931647A patent/ZA931647B/xx unknown
- 1993-03-08 HU HU9402582A patent/HUT68445A/hu unknown
- 1993-03-08 WO PCT/GB1993/000479 patent/WO1993018009A1/en active IP Right Grant
- 1993-03-08 AT AT93905536T patent/ATE170846T1/de not_active IP Right Cessation
- 1993-05-27 TW TW082104263A patent/TW366339B/zh active
-
1994
- 1994-09-08 FI FI944134A patent/FI944134A/fi unknown
- 1994-09-09 KR KR1019940703149A patent/KR950700887A/ko not_active Application Discontinuation
- 1994-09-09 US US08/304,006 patent/US5534535A/en not_active Expired - Lifetime
-
1995
- 1995-09-11 KR KR1019970701554A patent/KR970705547A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL104976A (en) | 1998-10-30 |
| IL104976A0 (en) | 1993-07-08 |
| AU672597B2 (en) | 1996-10-10 |
| RU2141952C1 (ru) | 1999-11-27 |
| KR950700887A (ko) | 1995-02-20 |
| JPH07506816A (ja) | 1995-07-27 |
| ZA931647B (en) | 1994-09-08 |
| DE69320945T2 (de) | 1999-02-04 |
| EP0630368A1 (en) | 1994-12-28 |
| FI944134A0 (fi) | 1994-09-08 |
| HUT68445A (en) | 1995-06-28 |
| KR970705547A (ko) | 1997-10-09 |
| GB9205071D0 (en) | 1992-04-22 |
| ES2123048T3 (es) | 1999-01-01 |
| EP0630368B1 (en) | 1998-09-09 |
| DE69320945D1 (de) | 1998-10-15 |
| AU3643293A (en) | 1993-10-05 |
| ATE170846T1 (de) | 1998-09-15 |
| US5534535A (en) | 1996-07-09 |
| DK0630368T3 (da) | 1999-06-07 |
| RU94043771A (ru) | 1996-08-10 |
| TW366339B (en) | 1999-08-11 |
| HU9402582D0 (en) | 1994-11-28 |
| CA2131693A1 (en) | 1993-09-16 |
| JP3450854B2 (ja) | 2003-09-29 |
| NZ249554A (en) | 1996-05-28 |
| CZ209494A3 (en) | 1995-11-15 |
| WO1993018009A1 (en) | 1993-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE170846T1 (de) | Antivirale nukleosidanaloge | |
| DK654287D0 (da) | Antivirale forbindelser | |
| DE3780581D1 (de) | Antiviralen phosphonomethoxyalkylen-purin- und -pyrimidin-derivate. | |
| DE19975068I2 (de) | Derivate und Analoge der 2-Deoxy-2,3-Didehydro-N-Acetyl-Neuraminsaeure und ihre Verwendung als antivirale Agentien | |
| DK214787D0 (da) | Furo-(3,4-d)-pyrimidin-2,4-dionderivater samt mel-lemprodukter deraf | |
| ATE63747T1 (de) | Antivirale verbindungen. | |
| MX9203217A (es) | Nucleosidos terapeuticos. | |
| ATE36331T1 (de) | Guanin-derivate, diese enthaltende zusammensetzungen und ihre antivirale wirkung. | |
| EP0453247A3 (en) | Anti-viral compounds |